Kyle Rizer
Impact in
- Neurology top 5%
- Neurological disorders and treatments
- Parkinson's Disease Mechanisms and Treatments
- Botulinum Toxin and Related Neurological Disorders
-
- Genetic Neurodegenerative Diseases
Papers in
-
- Parkinson's Disease Mechanisms and Treatments 3
- Neurological disorders and treatments 2
- Botulinum Toxin and Related Neurological Disorders 1
-
- Genetic Neurodegenerative Diseases 4
- Journals
- Neurology (2 papers)The Lancet Neurology (2 papers)Frontiers in Neuroscience (1 paper)CNS Drugs (1 paper)JAMA (1 paper)
- Partner nations
- United StatesUnited KingdomGermany
In The Last Decade
Kyle Rizer
12 papers receiving 776 citations
Peers
Comparison fields: 5 of 72
- Neurology 325
- Cellular and Molecular Neuroscience 206
- Clinical Psychology 175
- Pharmaceutical Science 19
- Psychiatry and Mental health 45
Countries citing papers authored by Kyle Rizer
This map shows the geographic impact of Kyle Rizer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kyle Rizer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kyle Rizer more than expected).
Fields of papers citing papers by Kyle Rizer
This network shows the impact of papers produced by Kyle Rizer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kyle Rizer. The network helps show where Kyle Rizer may publish in the future.
No co-authors to show.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 206 | |
| 2 | 2018 | 187 | |
| 3 | 2023 | 97 | |
| 4 | 2017 | 55 | |
| 5 | 2016 | 50 | |
| 6 | 2024 | 49 | |
| 7 | 2023 | 45 | |
| 8 | Effect of Deutetrabenazine on Chorea Among Patients With Huntington Disease A Randomized Clinical Trial | 2016 | 38 |
| 9 | 2017 | 36 | |
| 10 | 2022 | 25 | |
| 11 | Efficacy and Safety of Deep Brain Stimulation in Tourette Syndrome The International Tourette Syndrome Deep Brain Stimulation Public Database and Registry | 2018 | 19 |
| 12 | 2024 | 3 |
About Kyle Rizer
Kyle Rizer is a scholar working on Neurology, Cellular and Molecular Neuroscience, Clinical Psychology, Endocrinology, Diabetes and Metabolism and Psychiatry and Mental health, having authored 12 papers that have together received 810 indexed citations. Recurring topics across this work include Genetic Neurodegenerative Diseases (4 papers), Parkinson's Disease Mechanisms and Treatments (3 papers), Obsessive-Compulsive Spectrum Disorders (3 papers), Neurological disorders and treatments (2 papers), Telemedicine and Telehealth Implementation (1 paper), Neurological and metabolic disorders (1 paper), Dementia and Cognitive Impairment Research (1 paper) and Botulinum Toxin and Related Neurological Disorders (1 paper). The work is most often cited by research in Neurology (325 citations), Cellular and Molecular Neuroscience (206 citations), Clinical Psychology (175 citations), Pharmaceutical Science (19 citations) and Psychiatry and Mental health (45 citations). Kyle Rizer has collaborated with scholars based in United States, United Kingdom and Germany. Their work appears in journals such as Neurology, The Lancet Neurology, Frontiers in Neuroscience, CNS Drugs and JAMA.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.